Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects: Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions

Archives of Neurology

Volumn 54, Issue 3, 1997, Pages 267-272

  Skoog, Ingmar ^a   Hesse, Camilla ^a   Fredman, Pam ^a   Andreasson, Lars Arne ^a   Palmertz, Bo ^a   Blennow, Kaj ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMENTIA; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; WHITE MATTER;

EID: 0030962020     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550150029012     Document Type: Article

References (45)

1. Terry RD, Masliah E, Hansen LA. Structural basis of the cognitive alterations in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer Disease. New York, NY: Raven Press; 1994:179-196.
2. Wallin A, Blennow K. Heterogeneity of vascular dementia: mechanisms and subgroups. J Geriatr Psychiatry Neurol. 1993;6:177-188.
3. Skoog I. Risk factors for vascular dementia: a review. Dementia. 1994;5:137-144.
4. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
5. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541:163-166.
6. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992;135:235-238.
7. Zannis VI, Breslow JL, Utermann G, et al. Proposed nomenclature of ApoE isoproteins, ApoE genotypes, and phenotypes. J Lipid Res. 1982;23:911-914.
8. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
9. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342:697-699.
10. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
11. Strittmatter WJ, Saunders AM, Schmechel O, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
12. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA. 1993;90:8098-8102.
13. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem. 1994;269:23 403-23 406.
14. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filaments formation in the Alzheimer's disease brain are related to apolipoprotein E genotype. Exp Neurol. 1994;125:163-171.
15. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994;17:525-530.
16. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985;76:1501-1513.
17. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta. 1987;917:148-161.
18. Poirier J, Hess M, May PC, Finch CE. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res. 1991;11:97-106.
19. Roheim PS, Carey M, Forte T, Vega GL Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA. 1979;76:4646-4649.
20. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. Lipoproteins and their receptors in the central nervous system. J Biol Chem. 1987;262:14 352-14 360.
21. Blennow K, Hesse C, Fredman P. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport. 1994;5:2534-2536.
22. Lehtimäki T, Pirttilä T, Mehta PD, Wisniewski HM, Frey H, Nikkari T. Apolipoprotein E (ApoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum Genet. 1995;95:39-42.
23. Landén M, Hesse C, Fredman P, Regland B, Wallin A, Blennow K. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the ApoE4 isoform. Dementia. 1996;7:273-278.
24. Rosier N, Wichart I, Jellinger KA. Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996;60:452-454.
25. Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993;328:153-158.
26. Rinder L, Roupe S, Steen B, Svanborg A. Seventy-year-old people in Gothenburg: a population study in an industrialized Swedish city, I: general presentation of the study. Acta Med Scand. 1975;198:397-407.
27. Svanborg A. Seventy-year-old people in Gothenburg: a population study in an industrialized Swedish city, II: general presentation of social and medical conditions. Acta Med Scand, 1977;suppl 611:3-37.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Press; 1987.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
30. Romáan GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Work-shop. Neurology, 1993;43:250-260.
31. Blennow K, Fredman P, Wallin A, Gottfries CG, Långström L, Svennerholm L. Protein analyses in cerebrospinal fluid, I: influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. Eur Neurol. 1993;33:126-128.
32. Kane JW, Gowland G. A method for the identification of apolipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose. Ann Clin Biochem. 1986;23:509-513.
33. De Leon MJ, Ferris SH, George AE, Reisberg B, Kricneff II, Gershon S. Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer's type. Neurobiol Aging. 1980;1:69-79.
34. Skoog I, Palmertz B, Andreasson L-A. The prevalence of white matter lesions on computed tomography of the brain in demented and non-demented 85-year-olds. J Geriatr Psychiatry Neurol. 1994;7:169-175.
35. Linton MF, Gish R, Hubl ST, et al. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest. 1991;88:270-281.
36. Cox DR, Hinkley DV. Theoretical Statistics. New York, NY: Halsted Press; 1974:182-187.
37. Poirier J, Hess M, May PC, Pasinetti G, Finch CE. Astroglial gene expression in the hippocampus following partial deafferentiation in the rat and in Alzheimer's disease. In: Nagatsu T, ed. Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinsons Diseases. New York, NY: Plenum Publishing Corp; 1990:191-194.
38. Bertrand P, Poirier J, Oda T, Finch CE, Pasinetti GM, Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (cluslerin) in Alzheimer's disease. Mol Brain Res. 1995;33:174-178.
39. Snipes GJ, McGuire CB, Norden JJ, Freeman JA. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc Natl Acad Sci USA. 1986;83:1130-1134.
40. Ignatius MJ, Shooter EM, Pitas RE, Mahley RW. Lipoprotein uptake by neuronal growth cones in vitro. Science. 1987;236:959-962.
41. Poirier J, Baccicnet A, Dea D, Gautnier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience, 1993;55:81-90.
42. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993; 11:575-580.
43. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol. 1986;19:253-262.
44. Erkinjuntti T. Types of multi-infarct dementia. Acta Neurol Scand. 1987;75:391-399.
45. Wallin A, Blennow K, Uhlemann C, Långström G, Gottfries CG. White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia: diagnostic and pathogenic aspects. Acta Neurol Scand. 1989;80:518-523.